Search:
Login:
OR

Marijuana Blog

What strain are you smoking on today?

Category: Tokers | Posted on Wed, December, 23rd 2015 by THCFinder


Comments

Shatter, a super-high-potency marijuana, is appearing on the East Coast

Category: News | Posted on Wed, December, 23rd 2015 by THCFinder

As marijuana extracts expand their presence on the East Coast, an especially potent concentrate is appearing on law enforcement radar.

Shatter, a cannabis extract with about 80 percent THC content, is legal for recreational use in states such as Colorado and Washington, sold in medical marijuana dispensaries in other states and is faster-acting and far more easily concealed than marijuana.

On Monday, Loudoun County sheriff’s deputies intercepted a truck that had about $900,000 worth of packaged marijuana near Dulles International Airport. Included in that load was 15 pounds of shatter, in total packaged weight. Shatter, which is sold by the gram because of its potency, retails for about $60 a gram in Colorado, so 10 pounds of shatter would be worth nearly $270,000 — in a state where it is legal. Black-market shatter probably would cost much more.

Read More:https://www.washingtonpost.com/local/public-safety/shatter-super-high-potency-marijuana-now-appearing-on-east-coast/2015/12/23/e09dfde4-a8fa-11e5-bff5-905b92f5f94b_story.html


Comments

American Dad - Stan and Roger Stoned

Category: Videos | Posted on Wed, December, 23rd 2015 by THCFinder


Comments

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

Category: News | Posted on Wed, December, 23rd 2015 by THCFinder

cannabidiol cbd cannabis marijuanaThe United States Drug Enforcement Administration (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances Act (CSA) for those who are conducting FDA-approved clinical trials on cannabidiol (CBD), an extract of the marijuana plant.  These modifications will streamline the research process regarding CBD’s possible medicinal value and help foster ongoing scientific studies.  The DEA notified affected researchers by letter of the changes, which take effect immediately.

Federal Regulation (21 CFR 1301.18) requires researchers conducting CBD-based clinical trials under an FDA Investigational New Drug Application to have a DEA research registration.  This registration permits the possession of an approved amount of CBD for a specific research protocol.  Prior to now, researchers who expanded the scope of their studies and needed more CBD than initially approved for had to request, in writing, a modification to their DEA research registrations – potentially delaying that research while the modification underwent an approval process that includes both the DEA and the Food and Drug Administration (FDA).  Under these changes, a previously registered CBD clinical researcher who is granted a waiver can readily modify their protocol and continue their research seamlessly.  This waiver effectively removes a step from the approval process.

Read More:http://www.theweedblog.com/dea-eases-requirements-for-fda-approved-clinical-trials-on-cannabidiol/


Comments


Search







Blog Categories

Popular Articles

Latest Offers In Your Area
Recent Blog Posts
Download Our App!
21.3 Miles Away | Ventura thru TO,
7.7 Miles Away | Los Angeles,
15.4 Miles Away | Anaheim,
June 30, 2016 | Category: Fun
June 30, 2016 | Category: Legalization
June 30, 2016 | Category: Videos
Mobile Apps
Copyright 2016 THCFinder.com
All Rights Reserved.
Dispensaries      Strains      About Us      Friends      API / Widgets      Privacy Policy      Terms of Use      Investors      Contact Us